Filing Flows › Precigen (PGEN) › Recalls, complaints & regulation
Precigen (PGEN): clinical trials
Precigen (PGEN) beyond its filings: 6 active clinical trials.
Precigen's latest quarter
Precigen, Q3 2026: revenue $74.1M (25× year over year), operating margin 52.1%, net earnings $35.8M, operating cash flow $11.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Precigen have?
6 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.